47
Participants
Start Date
March 31, 2013
Primary Completion Date
August 31, 2016
Study Completion Date
August 31, 2016
Urelumab
Rituximab
Memorial Sloan Kettering Cancer Center, New York
Hospital Of The University Of Pennsylvania, Philadelphia
University Of Virginia School Of Medicine, Charlottesville
Levine Cancer Institute, Charlotte
University Of Miami Sylvester Comprehensive Cancer Center, Miami
Mount Sinai Comprehensive Cancer Center, Miami Beach
University Of Michigan Health System, Ann Arbor
Karmanos Cancer Institute, Detroit
University Of Iowa Hospitals And Clinics, Iowa City
The University Of Texas Md Anderson Cancer Center, Houston
Ucla Department Of Medicine, Los Angeles
Stanford University Medical Center, Stanford
Providence Cancer Center Oncology And Hematology Care- Eastside, Portland
Dana Faber Cancer Institute, Boston
John Theurer Cancer Center, Hackensack
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY